Field Trials of CBFeed on 41,000 Broilers: Results of a Joint Project with Poultry Management
CBF Animal Nutrition completed production trials of the CBFeed feed additive on a population of 41,000 broiler chickens in cooperation with Poultry Management. The trials were conducted under real production conditions throughout the full production cycle of 42 days — from the first days of the birds’ lives to the control slaughter on November 17, 2024.
Methodology
CBFeed was introduced into the broilers’ diet from the first days of life, at a dosage of 2.5–5.5% of the feed weight during the final week of the growing cycle. To ensure objective results, the control slaughter was carried out on 15 randomly selected chickens, selected by representatives of both parties. Throughout the entire cycle, the birds’ gastrointestinal tract and overall physiological condition were also monitored.
Results
The trials demonstrated a stable positive effect across key production indicators:
- Average daily weight gain increased by 7.1–11.5%
- Growth rate increased by 1.3–5.5%
- Feed conversion decreased by an average of 115.35% — the FCR improved from the standard 1.5 to 1.3
- Yield of individual carcass parts increased by 3–11%
Economic Effect
The economic analysis showed that the use of CBFeed is economically beneficial at two levels. First, the reduction in feed conversion provides direct savings on compound feed: for every sum spent on CBFeed, the farm saves an average of 11.62 sums on compound feed. Second, due to increased productivity, every sum spent on purchasing CBFeed generates an average of 25.93 sums in additional output value. The total return per sum invested is approximately 34.97 sums of additional value.
Commission Conclusions
Following the trials, the commission recommended CBFeed for widespread use in broiler diets at the established dosage rates. It was also specifically noted that the use of the additive throughout the entire production cycle did not have a negative effect on the gastrointestinal function of the birds.